{
    "nctId": "NCT02340169",
    "officialTitle": "An Open Label, Safety Study to Assess the Potential for Adrenal Suppression and Pharmacokinetics Following Maximal Use Treatment With Topicort\u00ae (Desoximetasone) Topical Spray, 0.25% in Pediatric Patients With Plaque Psoriasis.",
    "inclusionCriteria": "* Patients aged 7 years and older must have provided written assent accompanied by written informed consent from patient's representative\n* Clinical diagnosis of stable plaque psoriasis with involvement of \u2265 10% body surface area (excluding face and scalp)\n* Physicians Global Assessment score of 3 or 4 at baseline\n* Must have minimum age of 2 Years\n* Must have maximum age of 17 Years",
    "exclusionCriteria": "* Has other dermatological conditions that may interfere with clinical assessments\n* Allergy or sensitivity to corticosteroids or any drug hypersensitivity or intolerance that would compromise patient safety or study results\n* History of an adverse reaction to Cortrosyn\u2122 or similar test reagents\n* Chronic infectious disease, system or organ disorder or other medical condition that would place patient at undue risk by study participation"
}